Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kistarcsa – page 52

1 101 clinical trials in Kistarcsa, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kistarcsa at a glance
1 101
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 101 trials in Kistarcsa

Open in trial search

Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Prometheus Biosciences Inc.

Study of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Asparaginase
  • Sponsor:Amgen Inc.

A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Serplulimab
  • Sponsor:Shanghai Henlius Biotech Inc.

Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial

Investigational
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Odevixibat
  • Sponsor:Ipsen Pharma

Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm

Not recruiting

Phase 1 study of oral and intravenous unesbulin to assess absorption, metabolism and excretion in patients with solid tumors

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Unesbulin
  • Sponsor:PTC Therapeutics Inc.

Plasma cell myeloma

Not recruiting

Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited

Phase 1 Study of REN001 Single‑Dose Pharmacokinetics in Adults with Normal, Mild, Moderate, or Severe Liver Impairment

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Mavodelpar sodium
  • Sponsor:Reneo Pharmaceuticals Inc.

Pharmacokinetic Study of Oral TVB-2640 in Adults with Mild, Moderate, or Severe Hepatic Impairment and in Healthy Volunteers

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:TVB-2640
  • Sponsor:Sagimet Biosciences Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Kistarcsa

What the registry says about research in the country

01 Rheumatic and Inflammatory Conditions

Multiple clinical trials focusing on psoriatic arthritis and rheumatoid arthritis treatments, evaluating new therapeutic approaches for inflammatory joint conditions.

  • Psoriatic Arthritis Studies
  • Rheumatoid Arthritis Management
  • Non-radiographic Axial Spondyloarthritis

Research includes assessment of novel biologics and comparative effectiveness studies.

02 Cardiovascular Research

Innovative trials targeting atherosclerotic cardiovascular disease and various cardiovascular conditions, including studies on clot prevention and heart failure.

  • Deep Vein Thrombosis Treatment
  • Chronic Heart Failure Management
  • Stroke Prevention

Focus on both preventive measures and therapeutic interventions for cardiovascular health.

03 Neurological Disorders

Advanced research in multiple sclerosis treatment, particularly focusing on primary progressive MS and innovative therapeutic approaches.

  • Multiple Sclerosis Studies
  • Myasthenia Gravis Research
  • CNS Imaging Studies

Emphasis on long-term disease management and quality of life improvement.

04 Metabolic and Chronic Conditions

Studies addressing type 2 diabetes, obesity, and chronic kidney disease, exploring new treatment options and management strategies.

  • Weight Management Studies
  • Kidney Disease Research
  • Diabetes Management

Investigation of novel therapies for metabolic disorders and their complications.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.